Physician profile
Joshua J Wind
NPI 1013182294
$73,951.81
in general payments reported to CMS, 2019-2025
19 companies · $9,552 in 2025
The $9,552 reported for 2025 was more than what 85% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,476 · 2020: $8,426 · 2021: $143 · 2022: $18K · 2023: $16K · 2024: $19K · 2025: $9,552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Royalty Or License: $19K · Food and Beverage: $2,406 · Travel and Lodging: $1,879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,998.75 |
| Royalty Or License | $18,848.39 |
| Food and Beverage | $2,406.07 |
| Travel and Lodging | $1,878.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $40,912.81 | 2019-2025 | Walterlorenz Surgical Assist Arm |
| Centinel Spine, LLC | $16,937.50 | 2023-2025 | Prodisc C Sk, Prodisc C Vivo |
| Orthofix Medical, INC. | $9,742.06 | 2019-2024 | M6-C |
| Medtronic, INC. | $2,926.49 | 2021-2025 | Mazor X System, Unid_pass, Stealthstation S8 Platform |
| Depuy Synthes Products, INC. | $1,619.42 | 2019-2024 | Velys |
| Stryker Corporation | $980.44 | 2024-2025 | N/A, Mako, Vitoss |
| Boston Scientific Corporation | $229.63 | 2025 | Wavewriter Alpha Prime 16 |
| Kuros Biosciences USA, INC | $169.68 | 2022-2023 | |
| Nuvasive, INC. | $110.45 | 2019-2020 | |
| Medtronic USA, INC. | $87.78 | 2019-2020 | |
| Abbott Laboratories | $63.98 | 2024 | Proclaim |
| Depuy Synthes Sales INC. | $42.75 | 2022-2023 | Skyline |
| 4web, INC. | $28.88 | 2020 | |
| Inspire Medical Systems, INC. | $24.74 | 2024 | Inspire |
| Cerapedics INC. | $22.07 | 2023 | I-Factor Peptide Enhanced Bone Graft |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $21.77 | 2025 | |
| Theragen, INC. | $17.00 | 2025 | Actastim-S |
| Globus Medical, INC. | $14.36 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Wind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.